Morgan Stanley Lowers Meta Price Target to $775, Names New Top Pick

Morgan Stanley analyst Brian Nowak lowered the price target on Meta (NASDAQ: META) to $775.00 (from $825.00) while maintaining an Overweight rating.

“META sentiment has troughed due to GenAI ROIC and long-term positioning fears, and more recently macro ad market and regulatory question marks.

In all, META now trades at ~15X our ’27 $36 EPS, 1 standard deviation below the long-term average, which creates a strong buying opportunity, in our view.

Note too that our $36 of ’27 EPS 1) Considers some macro weakness (as we reduce ad estimates by 1% in ’26 to be more conservative) and 2) Does not factor in the potential $3-7bn of savings from the reported 20% potential workforce reductions (see here)…which all else equal could add $1+ to ’27 EPS (or provide cushion to our base case if ad markets weaken).

Our $775 PT has ~50% upside.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.